Selected article for: "disease burden and major infection"
Author: Romero, I. M.; Marcolino, M. S.; Pires, M. C.; Ramos, L. E. F.; Silva, R. T.; Guimaraes Junior, M. H.; Oliveira, I. J. R. d.; Carvalho, R. L. R. d.; Nunes, A. G. S.; Barros, A. L. R. M. d.; Scotton, A. L. B. A.; Madureira, A. A. C.; Farace, B. L.; Carvalho, C. A. d.; Rodrigues, F. d.; Anschau, F.; Botoni, F. A.; Nascimento, G. F.; Duani, H.; Guimaraes, H. C.; Alvarenga, J. C. d.; Moreira, L. B.; Zandona, L. B.; Almeida, L. F. d.; Oliveira, L. M.; Kopittke, L.; Castro, L. C. d.; Santos, L. E. A.; Cabral, M. A. d. S.; Ferreira, M. A. P.; Sampaio, N. d. C. S.; Oliveira, N. R. d.; Francisco, S. C.
Title: Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes: results from the Brazilian COVID-19 Registry
  • Cord-id: 9foasug4
  • Document date: 2021_3_26
    • ID: 9foasug4
    Snippet: Objective: Chagas disease (CD) continues to be a major public health burden in Latina America, where co-infection with SARS-CoV-2 can occur. However, information on the interplay between COVID-19 and Chagas disease is lacking. Our aim was to assess clinical characteristics and in-hospital outcomes of patients with CD and COVID-19, and to compare it to non-CD patients. Methods: Patients with COVID-19 diagnosis were selected from the Brazilian COVID-19 Registry, a prospective multicenter cohort, f
    Document: Objective: Chagas disease (CD) continues to be a major public health burden in Latina America, where co-infection with SARS-CoV-2 can occur. However, information on the interplay between COVID-19 and Chagas disease is lacking. Our aim was to assess clinical characteristics and in-hospital outcomes of patients with CD and COVID-19, and to compare it to non-CD patients. Methods: Patients with COVID-19 diagnosis were selected from the Brazilian COVID-19 Registry, a prospective multicenter cohort, from March to September, 2020. CD diagnosis was based on hospital record at the time of admission. Study data were collected by trained hospital staff using Research Electronic Data Capture (REDCap) tools. Genetic matching for sex, age, hypertension, DM and hospital was performed in a 4:1 ratio. Results: Of the 7,018 patients who had confirmed infection with SARS-CoV-2 in the registry, 31 patients with CD and 124 matched controls were included. Overall, the median age was 72 (64.-80) years-old and 44.5% were male. At baseline, heart failure (25.8% vs. 9.7%) and atrial fibrillation (29.0% vs. 5.6%) were more frequent in CD patients than in the controls (p<0.05 for both). C-reactive protein levels were lower in CD patients compared with the controls (55.5 [35.7, 85.0] vs. 94.3 [50.7, 167.5] mg/dL). Seventy-two (46.5%) patients required admission to the intensive care unit. In-hospital management, outcomes and complications were similar between the groups. Conclusions: In this large Brazilian COVID-19 Registry, CD patients had a higher prevalence of atrial fibrillation and chronic heart failure compared with non-CD controls, with no differences in-hospital outcomes. The lower C-reactive protein levels in CD patients require further investigation.

    Search related documents:
    Co phrase search for related documents
    • absolute number and acute severe pneumonia: 1, 2
    • absolute number and acute severe pneumonia respiratory distress syndrome: 1
    • ace inhibitor and acute heart failure: 1
    • ace inhibitor and acute severe pneumonia: 1
    • acute fulminant myocarditis and admission day: 1
    • acute heart failure and admission day: 1, 2, 3, 4
    • acute severe pneumonia and admission day: 1, 2, 3, 4, 5, 6, 7, 8
    • acute severe pneumonia and low median: 1
    • acute severe pneumonia respiratory distress syndrome and admission day: 1, 2
    • acute severe pneumonia respiratory distress syndrome and low median: 1
    • admission day and low income background: 1, 2, 3
    • admission day and low median: 1